Suppr超能文献

恶性疟原虫半胱氨酸蛋白酶疟原虫蛋白酶-2通过一个独特的基序捕获其底物血红蛋白。

The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

作者信息

Pandey Kailash C, Wang Stephanie X, Sijwali Puran S, Lau Anthony L, McKerrow James H, Rosenthal Philip J

机构信息

Department of Medicine, San Francisco General Hospital, P.O. Box 0811, University of California, San Francisco, CA 94143, USA.

出版信息

Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9138-43. doi: 10.1073/pnas.0502368102. Epub 2005 Jun 17.

Abstract

Falcipain-2 (FP2) is a papain family cysteine protease and important hemoglobinase of erythrocytic Plasmodium falciparum parasites. Inhibitors of FP2 block hemoglobin hydrolysis and parasite development, suggesting that this enzyme is a promising target for antimalarial chemotherapy. FP2 and related plasmodial cysteine proteases have an unusual 14-aa motif near the C terminus of the catalytic domain. Recent solution of the structure of FP2 showed this motif to form a beta-hairpin that is distant from the enzyme active site and protrudes out from the protein. To evaluate the function of this motif, we compared the activity of the wild-type enzyme with that of a mutant lacking 10 aa of the motif (Delta10FP2). Delta10FP2 had nearly identical activity to that of the wild-type enzyme against peptide substrates and the protein substrates casein and gelatin. However, Delta10FP2 demonstrated negligible activity against hemoglobin or globin. FP2 that was inhibited with trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (FP2E-64) formed a complex with hemoglobin, but Delta10FP2E-64 did not, indicating that the motif mediates binding to hemoglobin independent of the active site. A peptide encoding the motif blocked hemoglobin hydrolysis, but not the hydrolysis of casein. Kinetics for the inhibition of Delta10FP2 were very similar to those for FP2 with peptidyl and protein inhibitors, but Delta10FP2 was poorly inhibited by the inhibitory prodomain of FP2. Our results indicate that FP2 utilizes an unusual motif for two specific functions, interaction with hemoglobin, its natural substrate, and interaction with the prodomain, its natural inhibitor.

摘要

恶性疟原虫蛋白酶-2(FP2)是一种木瓜蛋白酶家族的半胱氨酸蛋白酶,也是恶性疟原虫红细胞内寄生虫重要的血红蛋白酶。FP2抑制剂可阻断血红蛋白水解和寄生虫发育,这表明该酶是抗疟化疗的一个有前景的靶点。FP2及相关的疟原虫半胱氨酸蛋白酶在催化结构域的C末端附近有一个不寻常的14个氨基酸的基序。最近对FP2结构的解析表明,这个基序形成了一个β-发夹结构,它远离酶的活性位点并从蛋白质中突出。为了评估这个基序的功能,我们比较了野生型酶与缺失该基序10个氨基酸的突变体(Delta10FP2)的活性。Delta10FP2对肽底物以及蛋白质底物酪蛋白和明胶的活性与野生型酶几乎相同。然而,Delta10FP2对血红蛋白或珠蛋白的活性可忽略不计。用反式环氧琥珀酰-L-亮氨酰胺基-(4-胍基)丁烷抑制的FP2(FP2E-64)与血红蛋白形成复合物,但Delta10FP2E-64则不能,这表明该基序介导与血红蛋白的结合且不依赖于活性位点。编码该基序的肽可阻断血红蛋白水解,但不能阻断酪蛋白的水解。Delta10FP2被肽基和蛋白质抑制剂抑制的动力学与FP2非常相似,但Delta10FP2被FP2的抑制性前结构域抑制的效果较差。我们的结果表明,FP2利用一个不寻常的基序实现两种特定功能,即与它的天然底物血红蛋白相互作用以及与它的天然抑制剂前结构域相互作用。

相似文献

引用本文的文献

4
Methods Used to Investigate the Digestive Vacuole.研究消化液泡的方法。
Front Cell Infect Microbiol. 2022 Jan 13;11:829823. doi: 10.3389/fcimb.2021.829823. eCollection 2021.
8
Structural Insights Into Key Proteases as Therapeutic Drug Targets.作为治疗药物靶点的关键蛋白酶的结构洞察
Front Microbiol. 2019 Mar 5;10:394. doi: 10.3389/fmicb.2019.00394. eCollection 2019.
9
Current scenario and future strategies to fight artemisinin resistance.对抗青蒿素耐药性的当前情况及未来策略
Parasitol Res. 2019 Jan;118(1):29-42. doi: 10.1007/s00436-018-6126-x. Epub 2018 Nov 26.

本文引用的文献

1
Cysteine proteases of malaria parasites.疟原虫的半胱氨酸蛋白酶
Int J Parasitol. 2004 Dec;34(13-14):1489-99. doi: 10.1016/j.ijpara.2004.10.003.
5
Antimalarial drug resistance.抗疟药耐药性。
J Clin Invest. 2004 Apr;113(8):1084-92. doi: 10.1172/JCI21682.
8
Antimalarial drug discovery: old and new approaches.抗疟药物研发:新旧方法
J Exp Biol. 2003 Nov;206(Pt 21):3735-44. doi: 10.1242/jeb.00589.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验